Global Oncology Academy

Diving into the Efficacy & Tolerability of mBC Treatment

ReachMD Healthcare Image

An oral chemotherapy drug is preferred by physicians and patients for mBC patients. However, the current approved dosing has cumulative toxicity.

  • Overview

    In a recent study, investigators conducted a randomized trial to compare the efficacy and tolerability of a fixed dose of an oral chemotherapy drug on a 7/7 schedule. Here with Dr. Pavani Chalasani to discuss the results from the X-7/7 trial is Dr. Colleen Bohnenkamp, Oncology Clinical Pharmacist who specializes in women’s cancers at the University of Kansas Cancer Center.

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free